Rock Springs Capital Management LP Q3 2018 Filing
Filed November 14, 2018
Portfolio Value
$2.8T
Holdings
144
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (144 positions)
| Stock | Value |
|---|---|
CBAYUSDCYMABAY THERAPEUTICS INC | $6.8M |
—DERMIRA INC | $6.5M |
—GLOBAL CORD BLOOD CORPORATIO | $6.5M |
RYTMRHYTHM PHARMACEUTICALS INC | $6.3M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $6.2M |
NVAXNOVAVAX INC | $6.1M |
IFRXINFLARX NV | $6.1M |
—RESTORBIO INC | $6.1M |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $6.0M |
MGNXMACROGENICS INC | $5.9M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $5.7M |
—LA JOLLA PHARMACEUTICAL CO | $5.7M |
SPROSPERO THERAPEUTICS INC | $5.5M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $5.4M |
—ALDER BIOPHARMACEUTICALS INC | $5.4M |
BCRXBIOCRYST PHARMACEUTICALS | $5.3M |
INSM 1.75 01/15/25INSMED INC | $5.1M |
CRVSCORVUS PHARMACEUTICALS INC | $4.9M |
—NABRIVA THERAPEUTICS PLC | $4.9M |
—CORREVIO PHARMA CORP | $4.8M |
—MEDICINES CO | $4.6M |
SLDBSOLID BIOSCIENCES INC | $4.5M |
—PARATEK PHARMACEUTICALS INC | $4.4M |
CGENCOMPUGEN LTD | $4.2M |
ITCIEURINTRA CELLULAR THERAPIES INC | $4.1M |
—CLEMENTIA PHARMACEUTICALS IN | $3.8M |
VKTXVIKING THERAPEUTICS INC | $3.5M |
—ALLERGAN PLC | $3.4M |
DVAXDYNAVAX TECHNOLOGIES CORP | $3.3M |
—MENLO THERAPEUTICS INC | $3.3M |
—MEDICINES CO | $3.2M |
ARVNARVINAS INC | $2.5M |
—CHIASMA INC | $1.9M |
—THERAVANCE BIOPHARMA INC | $1.8M |
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | $1.7M |
MCRB1EURSERES THERAPEUTICS INC | $1.7M |
—CIDARA THERAPEUTICS INC | $1.3M |
NVCRNOVOCURE LTD | $1.3M |
—UROVANT SCIENCES LTD | $1.2M |
—RADIUS HEALTH INC | $1.2M |
—PACIRA PHARMACEUTICALS INC | $1.1M |
SCYXEURSCYNEXIS INC | $984K |
—DERMIRA INC | $834K |
—GTX INC DEL | $79K |
PreviousPage 2 of 2